Total Payments
$31,347
2024 Payments
$1,650
Companies
9
Transactions
101

Payment Breakdown by Category

Research$23,800 (75.9%)
Consulting$6,450 (20.6%)
Food & Beverage$1,097 (3.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $23,800 25 75.9%
Consulting Fee $6,450 9 20.6%
Food and Beverage $1,097 67 3.5%

Payments by Type

Research
$23,800
25 transactions
General
$7,547
76 transactions

Top Paying Companies

Company Total Records Latest Year
Medtronic Vascular, Inc. $17,752 20 $0 (2020)
W. L. Gore & Associates, Inc. $6,450 9 $0 (2024)
Medtronic, Inc. $6,100 6 $0 (2024)
GlaxoSmithKline, LLC. $677.29 58 $0 (2023)
Janssen Pharmaceuticals, Inc $124.65 1 $0 (2023)
Abbott Laboratories $100.08 2 $0 (2018)
Boston Scientific Corporation $89.18 1 $0 (2019)
Electromed, Inc. $39.75 3 $0 (2017)
Gilead Sciences, Inc. $14.70 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,650 3 Medtronic, Inc. ($1,200)
2023 $4,388 11 Medtronic, Inc. ($2,600)
2022 $2,207 13 Medtronic, Inc. ($1,400)
2021 $1,620 12 Medtronic, Inc. ($900.00)
2020 $6,577 10 Medtronic Vascular, Inc. ($5,900)
2019 $4,309 18 Medtronic Vascular, Inc. ($2,900)
2018 $7,305 26 Medtronic Vascular, Inc. ($5,700)
2017 $3,292 8 Medtronic Vascular, Inc. ($3,252)

All Payment Transactions

101 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/13/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $450.00 General
Category: Devices
05/24/2024 Medtronic, Inc. HARMONY (Device) Cash or cash equivalent $200.00 Research
Study: Harmony PAS2 • Category: Heart Valves
02/16/2024 Medtronic, Inc. HARMONY (Device) Cash or cash equivalent $1,000.00 Research
Study: Harmony PAS2 • Category: Heart Valves
12/22/2023 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $450.00 General
Category: Devices
12/06/2023 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.70 General
08/25/2023 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $675.00 General
Category: Devices
08/25/2023 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $450.00 General
Category: Devices
07/28/2023 Medtronic, Inc. HARMONY (Device) Cash or cash equivalent $2,100.00 Research
Study: Harmony PAS2 • Category: Heart Valves
07/27/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $124.65 General
Category: Cardiovascular & Metabolism
06/14/2023 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $22.47 General
Category: RESPIRATORY
05/15/2023 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $16.11 General
Category: RESPIRATORY
03/13/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $21.80 General
Category: RESPIRATORY
02/06/2023 Medtronic, Inc. HARMONY (Device) Cash or cash equivalent $500.00 Research
Study: Harmony PAS2 • Category: Heart Valves
01/17/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $13.16 General
Category: RESPIRATORY
12/15/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $20.32 General
Category: RESPIRATORY
12/07/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $7.41 General
Category: RESPIRATORY
09/20/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $2.87 General
Category: RESPIRATORY
09/12/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $18.70 General
Category: RESPIRATORY
09/07/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $7.38 General
Category: RESPIRATORY
08/31/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $22.53 General
Category: RESPIRATORY
08/11/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $12.20 General
Category: RESPIRATORY
07/05/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $4.80 General
Category: RESPIRATORY
06/14/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $2.28 General
Category: RESPIRATORY
05/05/2022 Medtronic, Inc. HARMONY (Device) Cash or cash equivalent $1,400.00 Research
Study: Harmony PAS2 • Category: Heart Valves
04/22/2022 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $675.00 General
Category: Devices

Research Studies & Clinical Trials

Study Name Company Amount Records
Harmony TPV Pivotal Medtronic Vascular, Inc. $17,700 19
Harmony PAS2 Medtronic, Inc. $5,200 5
Harmony TPV Pivotal Medtronic, Inc. $900.00 1

About Jonathan Chen

Jonathan Chen is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972690071.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Chen has received a total of $31,347 in payments from pharmaceutical and medical device companies, with $1,650 received in 2024. These payments were reported across 101 transactions from 9 companies. The most common payment nature is "" ($23,800).

Practice Information

  • Specialty Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • Other Specialties Surgery
  • Location Seattle, WA
  • Active Since 10/09/2006
  • Last Updated 07/29/2013
  • Taxonomy Code 208G00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1972690071

Products in Payments

  • Product in Development (Device) $6,450
  • HARMONY (Device) $5,200
  • TRELEGY ELLIPTA (Drug) $514.29
  • XARELTO (Drug) $124.65
  • HeartMate 3 Left Ventricular Dev (Device) $100.08
  • GENERAL ONCOLOGY (Device) $89.18
  • ANORO (Drug) $58.93
  • NUCALA (Biological) $54.10
  • Mosaic (Device) $51.84
  • SMARTVEST (Device) $39.75
  • AREXVY (Drug) $38.58
  • ANORO ELLIPTA (Drug) $11.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Seattle